137 related articles for article (PubMed ID: 1848596)
21. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J
Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641
[TBL] [Abstract][Full Text] [Related]
22. Development of monoclonal antibodies and capture immunoassays for feline immunodeficiency virus.
Dreitz MJ; Dow SW; Fiscus SA; Hoover EA
Am J Vet Res; 1995 Jun; 56(6):764-8. PubMed ID: 7544555
[TBL] [Abstract][Full Text] [Related]
23. A recombinant-based feline immunodeficiency virus antibody enzyme-linked immunosorbent assay.
Mermer B; Hillman P; Harris R; Krogmann T; Tonelli Q; Palin W; Andersen P
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):133-41. PubMed ID: 1337392
[TBL] [Abstract][Full Text] [Related]
24. Studies on feline CD8+ T cell non-cytolytic anti-feline immunodeficiency virus (FIV) activity.
Hohdatsu T; Miyagawa N; Ohkubo M; Kida K; Koyama H
Arch Virol; 2000; 145(12):2525-38. PubMed ID: 11205103
[TBL] [Abstract][Full Text] [Related]
25. Densitometric analysis of Western blot assays for feline immunodeficiency virus antibodies.
Calandrella M; Matteucci D; Mazzetti P; Poli A
Vet Immunol Immunopathol; 2001 May; 79(3-4):261-71. PubMed ID: 11389960
[TBL] [Abstract][Full Text] [Related]
26. Neutralizing antibodies in cats infected with feline immunodeficiency virus.
Tozzini F; Matteucci D; Bandecchi P; Baldinotti F; Siebelink K; Osterhaus A; Bendinelli M
J Clin Microbiol; 1993 Jun; 31(6):1626-9. PubMed ID: 7686186
[TBL] [Abstract][Full Text] [Related]
27. Cross virus neutralizing antibodies against feline immunodeficiency virus genotypes A, B, C, D and E.
Inoshima Y; Miyazawa T; Kohmoto M; Ikeda Y; Sato E; Hohdatsu T; Mathiason-Dubard C; Hoover EA; Mikami T
Arch Virol; 1998; 143(1):157-62. PubMed ID: 9505973
[TBL] [Abstract][Full Text] [Related]
28. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
[TBL] [Abstract][Full Text] [Related]
29. DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus.
Cuisinier AM; Mallet V; Meyer A; Caldora C; Aubert A
Vaccine; 1997 Jul; 15(10):1085-94. PubMed ID: 9269051
[TBL] [Abstract][Full Text] [Related]
30. Retroviral vector-transduced cells expressing the core polyprotein induce feline immunodeficiency virus-specific cytotoxic T-lymphocytes from infected cats.
Li J; Brown WC; Song W; Carpino MR; Wolf AM; Grant CK; Elder JH; Collisson EW
Virus Res; 1995 Oct; 38(2-3):93-109. PubMed ID: 8578869
[TBL] [Abstract][Full Text] [Related]
31. [Quantification of feline immunodeficiency virus (FIV) RNA in the plasma of infected cats].
Vahlenkamp TW; De Ronde A; Horzinek MC; Egberink HF
Berl Munch Tierarztl Wochenschr; 1996 Aug; 109(8):265-9. PubMed ID: 9005834
[TBL] [Abstract][Full Text] [Related]
32. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.
Beatty JA; Willett BJ; Gault EA; Jarrett O
J Virol; 1996 Sep; 70(9):6199-206. PubMed ID: 8709246
[TBL] [Abstract][Full Text] [Related]
33. Detection of anti-gag antibodies of feline immunodeficiency virus in cat sera by enzyme-linked immunosorbent assay.
Furuya T; Hasegawa A; Miyazawa T; Miki K; Mikami T
Arch Virol; 1992; 124(3-4):355-61. PubMed ID: 1318710
[TBL] [Abstract][Full Text] [Related]
34. Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates.
Osborne R; Rigby M; Siebelink K; Neil JC; Jarrett O
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3641-5. PubMed ID: 7996159
[TBL] [Abstract][Full Text] [Related]
35. Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus.
Sparger EE; Beebe AM; Dua N; Himathongkam S; Elder JH; Torten M; Higgins J
Virology; 1994 Dec; 205(2):546-53. PubMed ID: 7975256
[TBL] [Abstract][Full Text] [Related]
36. Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats.
Inoshima Y; Kohmoto M; Ikeda Y; Yamada H; Kawaguchi Y; Tomonaga K; Miyazawa T; Kai C; Umemura T; Mikami T
J Virol; 1996 Dec; 70(12):8518-26. PubMed ID: 8970975
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical localization of feline immunodeficiency virus using native species antibodies.
Rogers AB; Mathiason CK; Hoover EA
Am J Pathol; 2002 Oct; 161(4):1143-51. PubMed ID: 12368188
[TBL] [Abstract][Full Text] [Related]
38. Mechanism(s) of FIV vaccine protection.
Pu R; Tellier MC; Yamamoto JK
Leukemia; 1997 Apr; 11 Suppl 3():98-101. PubMed ID: 9209311
[TBL] [Abstract][Full Text] [Related]
39. Immunization trial of cats with a replication-defective adenovirus type 5 expressing the ENV gene of feline immunodeficiency virus.
Gonin P; Fournier A; Oualikene W; Moraillon A; Eloit M
Vet Microbiol; 1995 Aug; 45(4):393-401. PubMed ID: 7483252
[TBL] [Abstract][Full Text] [Related]
40. Feline immunodeficiency virus replicates in salivary gland ductular epithelium during the initial phase of infection.
Park HS; Kyaw-Tanner M; Thomas J; Robinson WF
Vet Microbiol; 1995 Sep; 46(1-3):257-67. PubMed ID: 8545964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
